Showing results (1121-1130 of 4,563) with videos related to

Sort By:
Pageof 457
Schizophrenia Bulletin|September 3, 2026
A Dual Prediction Error Populations Model of Schizophrenia Spectrum Disorders: Bridging NMDA Hypofunction and Gain HyperfunctionShunsuke Sato, Tadahumi Kato, Taro Toyoizumi
Schizophrenia Bulletin|September 25, 2026
Reconceptualizing Schizophrenia through a Patient-Oriented Perspective: a Systematic Review and Qualitative Meta-SynthesisSofia Francesca Aprile, Alessandro Rodolico, Djordje Basic, et al.
Schizophrenia Bulletin|September 18, 2026
Evaluating the Prodromal Questionnaire-16 for Screening and Prediction of Psychosis in Autistic Adults: Cross-Sectional and Longitudinal Findings From a National CohortDjordje Basic, Sander Begeer, Tim Ziermans
Schizophrenia Bulletin|October 7, 2026
The Relationship between Air Pollution Exposure, Genetic Liability for Schizophrenia, and Brain Outcomes in the ABCD StudyGiulia Cattarinussi, Yingzhe Zhang, Fabio Sambataro, et al.
Schizophrenia Bulletin|October 28, 2026
Neurometabolic Differences in Psychosis Observed with 7 T Magnetic Resonance SpectroscopyMichael-Paul Schallmo, Caroline Demro, Kyle W Killebrew, et al.
Schizophrenia Bulletin|November 3, 2026
Neuroimaging of Clinical High-Risk Youth From the Kenya Psychosis-Risk Outcomes Study (KePROS): Regional Structural Analyses and Vertexwise Cortical Deviation Mapping (VCDM)Daniel Mamah, Michael P Harms, Victoria Mutiso, et al.
Schizophrenia Bulletin|November 3, 2026
Deficient Monetary Reward Processing in Schizophrenia: A Meta-Analysis and Computational Modeling of a Monetary Incentive Delay TaskJian Jiao, Xun Yang, Jianguang Zeng, et al.
Schizophrenia Bulletin|August 12, 2003
The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol developmentT Scott Stroup, Joseph P McEvoy, Marvin S Swartz, et al.
Schizophrenia Bulletin|August 12, 2003
Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationaleRichard S E Keefe, Richard C Mohs, Robert M Bilder, et al.
Schizophrenia Bulletin|August 12, 2003
Changing environments and alternative perspectives in evaluating the cost-effectiveness of new antipsychotic drugsRobert Rosenheck, Jefferson Doyle, Douglas Leslie, et al.
Pageof 457